Development of activators for SERCA2a for heart failure treatments
Open Access
- 29 November 2025
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 303, 118408
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HL139065)
- National Institutes of Health (R01AR082533)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Heart, Lung, and Blood Institute
This publication has 31 references indexed in Scilit:
- Allosteric Modulation of SERCA Pumps in Health and Disease: Structural Dynamics, Posttranslational Modifications, and Therapeutic PotentialJournal of Molecular Biology, 2025
- Machine Learning‐Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2aChemMedChem, 2025
- Quinoline‐ and Pyrimidine‐based Allosteric Modulators of the Sarco/Endoplasmic Reticulum Calcium ATPaseChemMedChem, 2024
- Interaction of DWORF with SERCA and PLB as determined by EPR spectroscopyBiochemical and Biophysical Research Communications, 2023
- New N-aryl-N-alkyl-thiophene-2-carboxamide compound enhances intracellular Ca2+ dynamics by increasing SERCA2a Ca2+ pumpingBiophysical Journal, 2022
- The transmembrane peptide DWORF activates SERCA2a via dual mechanismsJournal of Biological Chemistry, 2021
- Enhancing tetrandrine cytotoxicity in human lung carcinoma A549 cells by suppressing mitochondrial ATP productionNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- Ellagic acid and gingerol, activators of the sarco-endoplasmic reticulum Ca2+-ATPase, ameliorate diabetes mellitus-induced diastolic dysfunction in isolated murine ventricular myocardiaEuropean Journal of Pharmacology, 2013
- Utility of in vitro drug metabolism data in predicting in vivo metabolic clearanceBiochemical Pharmacology, 1994
- Highly purified sarcoplasmic reticulum vesicles are devoid of Ca2+-independent (‘basal’) ATPase activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980